Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
Fluticasone propionate and salmeterol
Medication labelFluticasone Propionate/Salmeterol Multidose Dry Powder Inhaler (FS MDPI) is indicated for the treatment of asthma in adult and pediatric…
Why this: Advisory · dailymed-prescription
Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhaler (FS MDPI) is indicated for the treatment of asthma in adult and pediatric patients aged 12 years and older. Fluticasone Propionate/Salmeterol MDPI should be used for patients not adequately controlled on a long term asthma control medication such as an inhaled corticosteroid or whose disease warrants initiation of treatment with both an inhaled corticosteroid and long acting beta2-adrenergic agonist (LABA). Limitations of Use: Fluticasone Propionate/Salmeterol MDPI is not indicated for the relief of acute bronchospasm.
- generic_name
- fluticasone propionate and salmeterol
- product_names
- Fluticasone Propionate and Salmeterol
- ndc
- 63629-8810, 0093-3609, 63629-8810-1
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en